Navigation Links
MAP Pharmaceuticals Reports Second Quarter of 2011 Financial Results
Date:8/4/2011

MOUNTAIN VIEW, Calif., Aug. 4, 2011 /PRNewswire/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced financial results for the second quarter ended June 30, 2011.

The net loss for the three months ended June 30, 2011 was $8.6 million compared to $12.5 million during the same period in 2010. The net income for the first six months of 2011 was $9.0 million compared to a net loss of $26.5 million during the same period in 2010.  Net income for the first six months of 2011 was impacted positively by $37.7 million in collaboration revenue recognized from a $60.0 million upfront payment received in February 2011 pursuant to a collaboration agreement with Allergan, Inc., compared to no collaboration revenue for the first six months of 2010.  

MAP Pharmaceuticals had $103.5 million in cash and cash equivalents as of June 30, 2011, compared to $76.0 million as of December 31, 2010.

"We completed a very productive second quarter of 2011 including the submission of our New Drug Application for LEVADEX to the U.S. Food and Drug Administration, which we recently announced was accepted for filing," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals. "This accomplishment brings us closer to our goal of providing millions of patients in an underserved migraine patient population with a potential new treatment option. We are now focusing our efforts on building infrastructure and preparing for the launch and commercialization of LEVADEX, if approved."

2011 Year-to-Date Accomplishments:

  • Announced a strategic collaboration with Allergan to co-promote LEVADEX® orally inhaled migraine drug, upon potential approval, to neurologists and pain specialists in the United States for the acute treatment of migraine in adults.  Allergan will leverage its existing U.S. sales force dedicated to headache special
    '/>"/>

  • SOURCE MAP Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Vanda Pharmaceuticals Reports Second Quarter 2011 Results
    2. Savient Pharmaceuticals Reports Second Quarter 2011 Financial Results
    3. Christian S. Schade to Join Omthera Pharmaceuticals as Executive Vice President and Chief Financial Officer
    4. Cadence Pharmaceuticals Reports Second Quarter 2011 Financial Results
    5. Onyx Pharmaceuticals Reports Second Quarter 2011 Financial Results
    6. Access Pharmaceuticals Adds Blue Cross Blue Shield of Hawaii, SummaCare and AvMed to MuGard Payer List
    7. Lyophilisation for Pharmaceuticals: Technology and Services Market 2011-2021 - What are the Revenue Prospects?
    8. Cadence Pharmaceuticals to Present at Two Investment Conferences During the Month of August 2011
    9. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
    10. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
    11. MAP Pharmaceuticals Announces FDA Acceptance for Filing of NDA for LEVADEX®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/1/2015)... , May 1, 2015 Semler Scientific, Inc. ... company that develops, manufactures and markets products that assist ... today reported financial results for the first quarter ended ... quarter of 2015, Semler reported continued progress with year ... quarter revenue growth of 14%," said Doug Murphy-Chutorian ...
    (Date:5/1/2015)...  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX ), a specialty ... innovative therapies for the treatment of acute and breakthrough ... chief financial officer  will be participating in three upcoming ... Mizuho Third Annual Healthcare Corporate Access Day ... New York Bank ...
    (Date:5/1/2015)... May 1, 2015  Shares of Aerie Pharmaceuticals, Inc. ... value yesterday following the results of the Phase 3 ... Despite the trial failing to meet its end points, ... may come from future studies. An analyst ... current pipeline, financial review, analyst summary, valuation, and recommendation ...
    Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
    ... , ALISO VIEJO, Calif., Nov. 17 OCTANe hosted ... companies to discuss promising technology and emerging trends for the ... Medical Device & Investor Forum. , For the first ... transactions in Orange County history discussed the details of the ...
    ... , NEW YORK, Nov. 17 Engineer/pilot/attorney Jon Roberts, ... They include technology that thwarts piracy in movie theatres, ... to enhance airport security and even an electronic matchmaker ... they have, indeed, found their match. Now, as ...
    Cached Medicine Technology:OCTANe's Medical Device & Investor Forum Highlights Key Trends, Investment Opportunities 2When Viruses (Including H1N1) and Bacteria are as Close as your Fingertips; VirWall's New Innovation Can Disarm Killer Keyboards 2
    (Date:5/2/2015)... (PRWEB) May 02, 2015 ZoomCare, the ... has submitted plans to offer its new healthcare insurance ... The ZOOM+ Personal Health Insurance System is the nation’s ... to enhance human performance. ZOOM+ Personal Health Insurance was ... delivery system that are subject to review and regulation ...
    (Date:5/1/2015)... (PRWEB) May 01, 2015 Pioneer Millworks, ... share the latest in their reclaimed wood products at ... the Jacob Javits Center in NYC this May. Their ... will bring much anticipated texture and color to North ... an explosion of texture and color in the design ...
    (Date:5/1/2015)... Mesa, CA (PRWEB) May 01, 2015 ... at the Cerner Southeast Regional User Group (RUG) Conference ... The Cerner Southeast Regional User Group Conference provides a ... to vendors who support all aspects of electronic medical ... use of Cerner software applications. , In addition to ...
    (Date:5/1/2015)... CA (PRWEB) May 01, 2015 The ... genetic makeup and the interplay of genes with one ... with developments can be daunting. , LabRoots, the premier ... clinical diagnostics professionals, will soon host its annual conference ... At BioConference Live Genetics and Genomics 2015 , ...
    (Date:5/1/2015)... Digital technology and Wi-Fi-enabled medical equipment may ... appointments, a preliminary study has shown. ... low-risk pregnant women, will be presented as a poster ... Associates at the 2015 American Congress of Obstetricians and ... The digital technology used was developed by Babyscripts™ ...
    Breaking Medicine News(10 mins):Health News:ZoomCare Applies to be on Oregon Exchange 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 2Health News:Intensely Textured Reclaimed Wood to be Unveiled at ICFF in NYC by Pioneer Millworks 3Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
    ... comes to estimating calorie counts, Americans aren,t really on ... Journal of Consumer Research , this may be ... food. "The sequence in which items are considered ... Alexander Chernev (Northwestern University). "The focus on sequential estimation ...
    ... By Kathleen Doheny HealthDay Reporter ... new studies may help breast cancer patients and ... reconstruction after mastectomy. One study finds that ... after having had a mastectomy with immediate reconstruction ...
    ... ultimate goal to discover a drug that one day treats ... on pinpointing the mechanisms in the brain that respond to ... in the UH College of Pharmacy, received a three-year, $450,000 ... In the end, his team hopes their research will help ...
    ... of prostate tumors, promotes the growth of a different type ... online on September 20 in the Journal of Experimental ... and colleagues find that TAL1, a protein abundantly expressed in ... (T-ALL), drives expression of NKX3.1. Eliminating NKX3.1 halted the ...
    ... might not benefit from some of the tuberculosis vaccines currently ... are designed to activate a specific molecule that is an ... people. But a recent Ohio State University study suggests that ... the face of TB infection. The animal research suggests ...
    ... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
    Cached Medicine News:Health News:Low-calorie cheesecake? Why we have trouble estimating calories 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:Drug to treat alcoholism goal of UH professor's research 2Health News:Elderly might not benefit from TB vaccines in development 2Health News:Elderly might not benefit from TB vaccines in development 3Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
    Integra Epilepsy grid electrodes are thin and flexible for easier placement and to conform to the curvature of the cortical surface. Lead tunneling is done using a 14-gauge tunneling needle (ET-2)....
    ...
    ... Electrodes feature exceptional quality and design to ... seizure recording technology. Neurosurgeons worldwide consider these ... flexible available. Our electrodes come in many ... 4-contact strips to 64-contact grids. Their bodies ...
    ... designed for laboratories looking for time and ... system operation in terms of easy reagent ... and on-board stability., ,URISYS 2400 is ... walk-away capability for medium to high volume ...
    Medicine Products: